Back To Schedule
Tuesday, March 14 • 9:00am - 9:45am
Panel: The Big Picture: Understanding Big Pharma’s Deal Drivers, Current Priorities and Processes

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
  • Identifying current priorities for big pharma including leading therapeutics areas for development and types of deals (i.e. – license vs. M&A)
  • How to identify and interact with the key decision-makers, including board members, to get buy-in for the deal and streamline the deal-making process
  • Understanding how pharma is assessing risk in the current economic climate
  • Discussing the factors taken into consideration when pharma is making strategic choices about which deals to move forward with

avatar for Chris DeRespino

Chris DeRespino

Chief Business Officer, 3T Biosciences
Chris DeRespino serves as chief business officer at 3T Biosciences, an industry leader in TCR targeting and therapeutics discovery. In this role, Mr. DeRespino is responsible for leading business development and corporate strategy. Previously, Mr. DeRespino was CBO and acting chief... Read More →

avatar for Niels Emmerich, Ph.D.

Niels Emmerich, Ph.D.

Vice President, Global Head Search & Evaluation, AbbVie, Inc.
After joining Abbott in 2011, Niels has held several positions with Abbott and, since its inception in 2013, AbbVie, currently serving in the Corporate Strategy Office as Vice President, Global Head of Search & Evaluation. Transactions that his group and Niels were involved in include... Read More →
avatar for Deepa Talpade

Deepa Talpade

Vice President, Head BD&L and Alliance Mgmt., Oncology, Bayer Pharmaceuticals
Deepa Talpade has over 20 years of experience in the Pharmaceutical Industry working in all phases of Business Development and across therapeutic areas combining extensive BD&L experience, business insight, strategic thinking, industry partnering and leadership experience in leading... Read More →
avatar for Siobhan Pomeroy

Siobhan Pomeroy

Vice President, Corporate Development, Gilead Sciences
avatar for Grace Han McMahon

Grace Han McMahon

AVP and Head, Pacific BD&L, Merck
Grace Han McMahon leads Merck’s Pacific Business Development & Licensing group in South San Francisco and Asia.  Her team focuses on preclinical through early clinical therapeutic opportunities (pre-proof of concept in patients) across multiple therapeutic areas and various modalities... Read More →

Tuesday March 14, 2023 9:00am - 9:45am PDT
Hyatt Centric Fisherman's Wharf San Francisco